Product Development Policy | Research & Development | SENJU Pharmaceutica
ratoconjunctivitis (an orphan disease), therapeutic drugs for glaucoma and ocular hypertension, and dry eye therapies. We also contributed to reducing the economic burden on patients by using various ...
http://www.senju.co.jp/english/rd/policy/